References
BROCHADO, A. R., TELZEROW, A., BOBONIS, J., BANZHAF, M., MATEUS, A.,
SELKRIG, J., HUTH, E., BASSLER, S., ZAMARRENO BEAS, J., ZIETEK, M., NG,
N., FOERSTER, S., EZRATY, B., PY, B., BARRAS, F., SAVITSKI, M. M., BORK,
P., GOTTIG, S. & TYPAS, A. 2018. Species-specific activity of
antibacterial drug combinations. Nature, 559, 259-263.
CHAROENPHOL, P. & BERMUDEZ, H. 2014. Aptamer-targeted DNA
nanostructures for therapeutic delivery. Molecular pharmaceutics,11, 1721-5.
DALY, S. M., STURGE, C. R., FELDER-SCOTT, C. F., GELLER, B. L. &
GREENBERG, D. E. 2017. MCR-1 Inhibition with Peptide-Conjugated
Phosphorodiamidate Morpholino Oligomers Restores Sensitivity to
Polymyxin in Escherichia coli. Mbio, 8.
EL-ANDALOUSSI, S., JARVER, P., JOHANSSON, H. J. & LANGEL, U. 2007.
Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating
peptides: a comparative study. The Biochemical journal,407, 285-92.
FRAZIER, K. S. 2015. Antisense Oligonucleotide Therapies: The Promise
and the Challenges from a Toxicologic Pathologist’s Perspective.Toxicologic Pathology, 43, 78-89.
GARCIA-CHAUMONT, C., SEKSEK, O., GRZYBOWSKA, J., BOROWSKI, E. & BOLARD,
J. 2000. Delivery systems for antisense oligonucleotides.Pharmacology & therapeutics, 87, 255-77.
GOOD, L., AWASTHI, S. K., DRYSELIUS, R., LARSSON, O. & NIELSEN, P. E.
2001. Bactericidal antisense effects of peptide-PNA conjugates.Nature biotechnology, 19, 360-4.
GOOD, L., SANDBERG, R., LARSSON, O., NIELSEN, P. E. & WAHLESTEDT, C.
2000. Antisense PNA effects in Escherichia coli are limited by the
outer-membrane LPS layer. Microbiology (Reading, England), 146 (
Pt 10), 2665-70.
GOODMAN, R. P., SCHAAP, I. A. T., TARDIN, C. F., ERBEN, C. M., BERRY, R.
M., SCHMIDT, C. F. & TURBERFIELD, A. J. 2005. Rapid chiral assembly of
rigid DNA building blocks for molecular nanofabrication. Science
(New York, N Y ), 310, 1661-5.
HEGARTY, J. P. & STEWART, D. B., SR. 2018. Advances in therapeutic
bacterial antisense biotechnology. Appl Microbiol Biotechnol,102, 1055-1065.
HU, Y., CHEN, Z., ZHANG, H., LI, M., HOU, Z., LUO, X. & XUE, X. 2017.
Development of DNA tetrahedron-based drug delivery system. Drug
delivery, 24, 1295-1301.
KIM, K.-R., KIM, D.-R., LEE, T., YHEE, J. Y., KIM, B.-S., KWON, I. C. &
AHN, D.-R. 2013. Drug delivery by a self-assembled DNA tetrahedron for
overcoming drug resistance in breast cancer cells. Chemical
communications (Cambridge, England), 49, 2010-2.
KIM, W., ZHU, W., HENDRICKS, G. L., VAN TYNE, D., STEELE, A. D.,
KEOHANE, C. E., FRICKE, N., CONERY, A. L., SHEN, S., PAN, W., LEE, K.,
RAJAMUTHIAH, R., FUCHS, B. B., VLAHOVSKA, P. M., WUEST, W. M., GILMORE,
M. S., GAO, H., AUSUBEL, F. M. & MYLONAKIS, E. 2018. A new class of
synthetic retinoid antibiotics effective against bacterial persisters.Nature, 556, 103-107.
LEE, D. S., QIAN, H., TAY, C. Y. & LEONG, D. T. 2016. Cellular
processing and destinies of artificial DNA nanostructures. Chem
Soc Rev, 45, 4199-225.
LEE, H., LYTTON-JEAN, A. K. R., CHEN, Y., LOVE, K. T., PARK, A. I.,
KARAGIANNIS, E. D., SEHGAL, A., QUERBES, W., ZURENKO, C. S., JAYARAMAN,
M., PENG, C. G., CHARISSE, K., BORODOVSKY, A., MANOHARAN, M., DONAHOE,
J. S., TRUELOVE, J., NAHRENDORF, M., LANGER, R. & ANDERSON, D. G. 2012.
Molecularly self-assembled nucleic acid nanoparticles for targeted in
vivo siRNA delivery. Nature nanotechnology, 7, 389-93.
LINKO, V., ORA, A. & KOSTIAINEN, M. A. 2015. DNA Nanostructures as
Smart Drug-Delivery Vehicles and Molecular Devices. Trends in
biotechnology, 33, 586-594.
MENG, J., HE, G., WANG, H., JIA, M., MA, X., DA, F., WANG, N., HOU, Z.,
XUE, X., LI, M., ZHOU, Y. & LUO, X. 2015. Reversion of antibiotic
resistance by inhibiting mecA in clinical methicillin-resistant
Staphylococci by antisense phosphorothioate oligonucleotide. The
Journal of antibiotics, 68, 158-64.
READMAN, J. B., DICKSON, G. & COLDHAM, N. G. 2017. Tetrahedral DNA
Nanoparticle Vector for Intracellular Delivery of Targeted Peptide
Nucleic Acid Antisense Agents to Restore Antibiotic Sensitivity in
Cefotaxime-Resistant Escherichia coli. Nucleic acid therapeutics,27, 176-181.
ROWNICKI, M., WOJCIECHOWSKA, M., WIERZBA, A. J., CZARNECKI, J.,
BARTOSIK, D., GRYKO, D. & TRYLSKA, J. 2017. Vitamin B12 as a carrier of
peptide nucleic acid (PNA) into bacterial cells. Scientific
reports, 7, 7644.
SETYAWATI, M. I., KUTTY, R. V., TAY, C. Y., YUAN, X., XIE, J. P. &
LEONG, D. T. 2014. Novel Theranostic DNA Nanoscaffolds for the
Simultaneous Detection and Killing of Escherichia coli and
Staphylococcus aureus. Acs Applied Materials & Interfaces,6, 21822-21831.
WALSH, A. S., YIN, H., ERBEN, C. M., WOOD, M. J. A. & TURBERFIELD, A.
J. 2011. DNA cage delivery to mammalian cells. ACS nano,5, 5427-32.
XIA, Z., WANG, P., LIU, X., LIU, T., YAN, Y., YAN, J., ZHONG, J., SUN,
G. & HE, D. 2016. Tumor-Penetrating Peptide-Modified DNA Tetrahedron
for Targeting Drug Delivery. Biochemistry, 55, 1326-31.
ZHANG, Y., MA, W., ZHU, Y., SHI, S., LI, Q., MAO, C., ZHAO, D., ZHAN,
Y., SHI, J., LI, W., WANG, L., FAN, C. & LIN, Y. 2018. Inhibiting
Methicillin-Resistant Staphylococcus aureus by Tetrahedral DNA
Nanostructure-Enabled Antisense Peptide Nucleic Acid Delivery.Nano letters .